You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API zolmitriptan


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing zolmitriptan

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Rebel Distributors Corp ZOMIG zolmitriptan 21695-955 CITRIC ACID ANHYDROUS
Rebel Distributors Corp ZOMIG zolmitriptan 21695-955 NITROGEN
Rebel Distributors Corp ZOMIG zolmitriptan 21695-955 SODIUM PHOSPHATE, DIBASIC
Rebel Distributors Corp ZOMIG zolmitriptan 21695-955 WATER
Amneal Pharmaceuticals LLC ZOMIG zolmitriptan 64896-083 ANHYDROUS CITRIC ACID
Amneal Pharmaceuticals LLC ZOMIG zolmitriptan 64896-083 NITROGEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing zolmitriptan

Company Ingredient NDC Excipient
Rising Pharma Holdings Inc zolmitriptan 16571-803 ANHYDROUS LACTOSE
Rising Pharma Holdings Inc zolmitriptan 16571-803 CELLULOSE, MICROCRYSTALLINE
Rising Pharma Holdings Inc zolmitriptan 16571-803 FERRIC OXIDE YELLOW
Rising Pharma Holdings Inc zolmitriptan 16571-803 HYPROMELLOSE 2910
Rising Pharma Holdings Inc zolmitriptan 16571-803 MAGNESIUM STEARATE
Rising Pharma Holdings Inc zolmitriptan 16571-803 POLYETHYLENE GLYCOL 4000
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for zolmitriptan

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ASPARTAME

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID ANHYDROUS

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

zolmitriptan drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Rising Pharma Holdings Inc zolmitriptan 16571-803
Rebel Distributors Corp zolmitriptan 21695-955
Ajanta Pharma USA Inc zolmitriptan 27241-021
Camber Pharmaceuticals Inc zolmitriptan 31722-458
Padagis Israel Pharmaceuticals Ltd zolmitriptan 45802-711
Alembic Pharmaceuticals Limited zolmitriptan 46708-181
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE I-A

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: NITROGEN

Excipient focus: ORANGE

Excipient focus: PEPPERMINT

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links